Common Stock, Shares, Outstanding of AGILE THERAPEUTICS INC from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Agile Therapeutics Inc quarterly Common Stock, Shares, Outstanding history and change rate from Q4 2013 to Q2 2024.
  • Agile Therapeutics Inc Common Stock, Shares, Outstanding for the quarter ending 30 Jun 2024 was 6.9M shares, a 321% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

AGILE THERAPEUTICS INC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q2 2024 6.9M +5.26M +321% 30 Jun 2024 10-Q 12 Aug 2024
Q1 2024 6.86M +5.92M +636% 31 Mar 2024 10-Q 15 May 2024
Q4 2023 2.96M +2.1M +245% 31 Dec 2023 10-Q 12 Aug 2024
Q3 2023 2.28M -36.7M -94.2% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 1.64M -10.7M -86.7% 30 Jun 2023 10-Q 09 Aug 2023
Q1 2023 932K -2.43M -72.3% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 859K -2.18M -71.7% 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 39M -55.7M -58.8% 30 Sep 2022 10-Q 07 Nov 2022
Q2 2022 12.4M -80.6M -86.7% 30 Jun 2022 10-Q 11 Aug 2022
Q1 2022 3.37M -84.9M -96.2% 31 Mar 2022 10-Q 12 May 2022
Q4 2021 3.03M -84.5M -96.5% 31 Dec 2021 10-K 23 Mar 2023
Q3 2021 94.7M +7.29M +8.34% 30 Sep 2021 10-Q/A 30 Dec 2021
Q2 2021 92.9M +5.63M +6.45% 30 Jun 2021 10-Q 26 Jul 2021
Q1 2021 88.3M +1.05M +1.21% 31 Mar 2021 10-Q 04 May 2021
Q4 2020 87.6M +17.8M +25.4% 31 Dec 2020 10-K 30 Mar 2022
Q3 2020 87.4M +28.1M +47.4% 30 Sep 2020 10-Q 12 Nov 2020
Q2 2020 87.3M +42.7M +95.6% 30 Jun 2020 10-Q 11 Aug 2020
Q1 2020 87.2M +43.6M +100% 31 Mar 2020 10-Q 05 May 2020
Q4 2019 69.8M +35.4M +103% 31 Dec 2019 10-K 01 Mar 2021
Q3 2019 59.3M +24.9M +72.5% 30 Sep 2019 10-Q 28 Oct 2019
Q2 2019 44.6M +10.3M +29.8% 30 Jun 2019 10-Q 01 Aug 2019
Q1 2019 43.6M +9.37M +27.4% 31 Mar 2019 10-Q 03 May 2019
Q4 2018 34.4M +191K +0.56% 31 Dec 2018 10-K 20 Feb 2020
Q3 2018 34.4M +219K +0.64% 30 Sep 2018 10-Q 02 Nov 2018
Q2 2018 34.4M +5.57M +19.3% 30 Jun 2018 10-Q 03 Aug 2018
Q1 2018 34.2M +5.47M +19% 31 Mar 2018 10-Q 07 May 2018
Q4 2017 34.2M +5.43M +18.9% 31 Dec 2017 10-K 12 Mar 2019
Q3 2017 34.2M +5.4M +18.8% 30 Sep 2017 10-Q 06 Nov 2017
Q2 2017 28.8M +53.7K +0.19% 30 Jun 2017 10-Q 28 Jul 2017
Q1 2017 28.8M +38.3K +0.13% 31 Mar 2017 10-Q 08 May 2017
Q4 2016 28.8M +6.44M +28.9% 31 Dec 2016 10-K 12 Mar 2018
Q3 2016 28.8M +6.47M +29% 30 Sep 2016 10-Q 07 Nov 2016
Q2 2016 28.8M +6.51M +29.3% 30 Jun 2016 10-Q 08 Aug 2016
Q1 2016 28.7M +6.58M +29.7% 31 Mar 2016 10-Q 09 May 2016
Q4 2015 22.3M +3.68M +19.8% 31 Dec 2015 10-K 15 Mar 2017
Q3 2015 22.3M +3.7M +19.9% 30 Sep 2015 10-Q 09 Nov 2015
Q2 2015 22.2M +3.65M +19.6% 30 Jun 2015 10-Q 13 Aug 2015
Q1 2015 22.2M 31 Mar 2015 10-Q 12 May 2015
Q4 2014 18.6M +18.5M +17898% 31 Dec 2014 10-K 09 Mar 2016
Q3 2014 18.6M 30 Sep 2014 10-Q 13 Nov 2014
Q2 2014 18.6M 30 Jun 2014 10-Q 14 Aug 2014
Q4 2013 104K 31 Dec 2013 10-K 26 Mar 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.